Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-669899f699-g7b4s Total loading time: 0 Render date: 2025-05-07T05:07:56.304Z Has data issue: false hasContentIssue false

40 - VZV: persistence in the population: transmission and epidemiology

from Part III - Pathogenesis, clinical disease, host response, and epidemiology: VZU

Published online by Cambridge University Press:  24 December 2009

By
Jane Seward  and
Aisha Jumaan
Edited by
Ann Arvin ,
Gabriella Campadelli-Fiume ,
Edward Mocarski ,
Patrick S. Moore ,
Bernard Roizman ,
Richard Whitley  and
Koichi Yamanishi
Jane Seward
Affiliation:
National Immunization Program Centers for Disease Control and Prevention, Atlanta, GA, USA
Aisha Jumaan
Affiliation:
National Immunization Program Centers for Disease Control and Prevention, Atlanta, GA, USA
Ann Arvin
Affiliation:
Stanford University, California
Gabriella Campadelli-Fiume
Affiliation:
Università degli Studi, Bologna, Italy
Edward Mocarski
Affiliation:
Emory University, Atlanta
Patrick S. Moore
Affiliation:
University of Pittsburgh
Bernard Roizman
Affiliation:
University of Chicago
Richard Whitley
Affiliation:
University of Alabama, Birmingham
Koichi Yamanishi
Affiliation:
University of Osaka, Japan
Get access

Summary

Like other herpes viruses, varicella zoster virus (VZV) causes disease due to the primary infection (varicella) and due to reactivation (herpes zoster). However, VZV differs from other herpes viruses in causing primary and reactivation infections that are easily recognized clinical diseases, even by the lay public. Because of this, the epidemiology of varicella and herpes zoster has been well described from clinically recognized disease (incidence, severe disease outcomes and deaths) with seroprevalence data providing additional information on the epidemiology of varicella especially in populations where varicella disease history may not be available.

Varicella occurs worldwide with ongoing endemic transmission in areas where populations are sufficiently large to support such transmission. However the epidemiology of varicella varies between temperate and tropical climates (Lee, 1998). Universal childhood vaccination programs have changed the epidemiology of varicella in countries implementing such programs with significant declines in disease. Most experience has been gained in the United States where a varicella vaccination program was initiated in 1995. Herpes zoster infections also occur throughout the world although the epidemiology of herpes zoster is less well described globally. Because the incidence of herpes zoster increases dramatically with age, countries with lower life expectancies may have lower health burdens due to this disease. A vaccine for prevention of herpes zoster and post-herpetic neuralgia was licensed in the USA in May, 2006 (Oxman et al., 2005). This chapter reviews pre- and post-vaccine epidemiology of varicella and herpes zoster.

Type
Chapter
Information
Human Herpesviruses
Biology, Therapy, and Immunoprophylaxis
 , pp. 713 - 734
Publisher: Cambridge University Press
Print publication year: 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Arvin, A. M. (1996). Varicella-zoster virus: overview and clinical manifestations. Semin. Dermatol., 15(2 Suppl. 1), 4–7. Review.Google ScholarPubMed
Arvin, A. M., Koropchak, C. M., and Wittek, A. E., (1983). Immunological evidence of re-infection with varicella zoster virus. J. Infect. Dis., 148, 200–205.CrossRefGoogle Scholar
Asano, Y., Nakayama, H., Yazaki, T.et al. (1977). Protection against varicella in family contacts by immediate inoculation with live varicella vaccine. Pediatrics, 59, 3–7.Google ScholarPubMed
Barzaga, N. G., Roxas, J. R., and Florese, R. H. (1994). Varicella zoster virus prevalence in metro Manila, Philippines. J. Am. Med. Assoc. (SE Asia), 274, S633–S635.Google Scholar
Battcock, T. M., Finn, R., Barnes, R. M.et al. (1990). Observations on herpes zoster: 1. Residual scarring and post-herpetic neuralgia; 2. Handedness and the risk of infection. Br. J. Clin. Pract., 44(12), 596–598.Google ScholarPubMed
Boelle, P. Y. and Hanslik, T. (2002). Varicella in non-immune persons: incidence, hospitalization and mortality rates. Epidemiol. Infect., 129, 599–606.CrossRefGoogle ScholarPubMed
Bowsher, D. (1999). The lifetime occurrence of herpes zoster and prevalence of postherpetic neuralgia: a retrospective survey in an elderly population. Eur. J. Pain, 3, 335–342.CrossRefGoogle Scholar
Bramley, J. C. and Jones, I. G. (2000). Epidemiology of chickenpox in Scotland: 1981 to 1998. Commun. Dis. Public Health, 3, 82–87.Google ScholarPubMed
Brisson, M. and Edmunds, J. W. (2003). Epidemiology of Varicella-Zoster Virus in England and Wales. J. Med. Virol., 70(Suppl 1), S9–S14.CrossRefGoogle ScholarPubMed
Brisson, M., Edmunds, W. J., Law, B.et al. (2001). Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol. Infect., 127(2), 305–314.CrossRefGoogle ScholarPubMed
Brisson, M., Gay, N. J., Edmunds, W. J.et al. (2002). Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine, 20(19–20), 2500–2507.CrossRefGoogle ScholarPubMed
Buchbinder, S. P., Katz, M. H., Hessol, N. A.et al. (1992). Herpes zoster and human immunodeficiency virus infection. J. Infect. Dis., 166(5), 1153–1156.CrossRefGoogle ScholarPubMed
Centers for Disease Control and Prevention. (2003). Decline in annual incidence of varicella – selected states, 1990–2001. Morb. Mortal. Wkly Rep., 52(37), 884–885.
Chant, K. G., Sullivan, E. A., Burgess, M. A.et al. (1998). Varicella-zoster virus infection in Australia. Aust. N Z J. Public Health, 22, 413–418.CrossRefGoogle ScholarPubMed
Chidiac, C., Bruxelle, J., Daures, J. P.et al. (2001). Characteristics of patients with herpes zoster on presentation to practitioners in France. Clin. Infect. Dis, 33, 62–69.CrossRefGoogle ScholarPubMed
Choo, P. W., Donahue, J. G., Manson, J. E., and Platt, R. (1995). The epidemiology of varicella and its complications. J. Infect. Dis., 172, 706–712.CrossRefGoogle ScholarPubMed
Choo, P. W., Galil, K., Donahue J. G. et al. (1997). Risk factors for postherpetic neuralgia. Arch. Intern. Med., 157(11), 1217–1224.CrossRefGoogle ScholarPubMed
Cooper, M. (1987). The epidemiology of herpes zoster. Eye, 1(Pt 3), 413–421.CrossRefGoogle ScholarPubMed
Coplan, P., Black, S., Rojas, C.et al. (2001). Incidence and hospitalization rates of varicella and herpes zoster before varicella vaccine introduction: a baseline assessment of the shifting epidemiology of varicella disease. Pediatr. Infect. Dis., 20(7), 641–645.CrossRefGoogle ScholarPubMed
Davis, M. M., Patel, M. S., Chen, B. S.et al. (2004). Decline in varicella-related hospitalization and expenditures for children and adults after introduction of varicella vaccine in the United States. Pediatrics, 114(3), 786–792.CrossRefGoogle ScholarPubMed
Decroix, J., Partsch, H., Gonzalez, R.et al. (2000). Factors influencing pain outcome in herpes zoster: an observational study with valaciclovir. Valaciclovir International Zoster Assessment Group (VIZA). J. Eur. Acad. Dermatol. Venereol., 14(1), 23–33.CrossRefGoogle Scholar
Degeun, S., Chau, N. P., and Flahault, A. (1998). Epidemiology of chickenpox in France (1991–1995). J. Epidemiol. Commun. Health, 52, 46S–98S.Google Scholar
di Luzio Paparatti, U., Arpinelli, F., and Visona, G. (1999). Herpes zoster and its complications in Italy: an observational survey. J. Infect., 38(2), 116–120.CrossRefGoogle ScholarPubMed
Donahue, J. G., Choo, P. W., and Manson, J. E. (1995). The incidence of herpes zoster. Arch. Intern. Med., 155, 1605–1609.CrossRefGoogle ScholarPubMed
Dworkin, R. H., Nagasako, E. M., Johnson, R. W., and Griffin, D. R. (2001). Acute pain in herpes zoster: the famciclovir database project. Pain, 94(1), 113–119.CrossRefGoogle ScholarPubMed
Dworkin, M. S., Jennings, C. E., Roth-Thomas, J.et al. (2002). An Outbreak of Varicella among children attending preschool and elementary school in Illinois. Clin. Infect. Dis., 35(1), 102–104. Epub 2002 Jun 05.CrossRefGoogle ScholarPubMed
Edmunds, W. J., Brisson, M., and Rose, J. D. (2001). The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales. Vaccine, 19(23–24), 3076–3090.CrossRefGoogle ScholarPubMed
Enders, G. and Miller, E. (2000). Varciella and herpes zoster in pregnancy and the newborn. In Arvin, A. and Gershon, A, eds. Varicella-Zoster Virus, pp. 317–347. Cambridge: Cambridge University Press.
Enders, G., Miller, E., Cradock-Watson, J.et al. (1994). Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet, 343(8912), 1548–1551.CrossRefGoogle ScholarPubMed
Fairley, C. K. and Miller, E. (1996). Varicella-zoster virus epidemiology – a changing scene?J. Infect. Dis., 174(suppl 3), S314–S319.CrossRefGoogle ScholarPubMed
Fales, W. T. (1928). The age distribution of whooping cough, measles, chickenpox, scarlet fever and diphtheria in various areas in the United States. Am. J. Hyg., 8, 759–799.Google Scholar
Feld, R., Evans, W. K., and DeBoer, G. (1980). Herpes zoster in patients with small-cell carcinoma of the lung receiving combined modality treatment. Ann. Intern. Med., 93(2), 282–283.CrossRefGoogle ScholarPubMed
Fornaro, P., Gandini, F., Marin, M.et al. (1999). Epidemiology and cost analysis of varicella in Italy: results of a sentinel study in the pediatric practice. Pediatr. Infect. Dis. J., 18, 414–419.CrossRefGoogle ScholarPubMed
Gabutti, G., Penna, C., Rossi, M.et al. (2001). The seroepidemiology of varicella in Italy. Epidemiol. Infect., 126, 433–440.CrossRefGoogle ScholarPubMed
Galil, K., Choo, P. W., Donahue, J. G., and Platt, R. (1997). The sequelae of herpes zoster. Arch. Intern. Med., 157(11), 1209–1213.CrossRefGoogle ScholarPubMed
Galil, G., Brown, C., Lin, F., and Seward, J. (2002a). Hospitalizations for varicella in the United States, 1988–1999. Pediatr. Infect. Dis. J., 21, 931–934.CrossRefGoogle Scholar
Galil, K., Lee, B., Strine, T.et al. (2002b). Outbreak of varicella at a day-care center despite vaccination. N. Engl. J. Med., 347(24), 1909–1915.CrossRefGoogle Scholar
Galil, K., Pletcher, M. J., Wallace, B. J.et al. (2002c). Tracking varicella deaths: accuracy and completeness of death certificates and hospital discharge records, New York State, 1989–1995. Am. J. Public Health, 92, 1248–1250.CrossRefGoogle Scholar
Garnett, G. P. and Ferguson, N. M. (1996). Predicting the Effect of Varicella Vaccine on Subsequent Cases of Zoster and Varicella. Rev. Med. Virol., 6(3), 151–161.3.0.CO;2-V>CrossRefGoogle ScholarPubMed
Garnett, G. P. and Grenfell, B. T. (1992). The epidemiology of varicella-zoster virus infections: the influence of varicella on the prevalence of herpes zoster. Epidemiol. Infect., 108(3), 513–528.CrossRefGoogle ScholarPubMed
Garnett, G. P., Cox, M. J., Bundy, D. A. P.et al. (1993). The age of infection with varicella-zoster virus in St, Lucia, West Indies. Epidemiol. Infect., 110, 361–372.CrossRefGoogle Scholar
Gershon, A. A., LaRussa, P., Steinberg, S.et al. (1996). The protective effect of immunologic boosting against zoster: an analysis in leukemic children who were vaccinated against chickenpox. J. Infect. Dis., 173(2), 450–453.CrossRefGoogle ScholarPubMed
Gershon, A., Takahashi, M., and Seward, J. (2004). Varicella vaccine. In Vaccines, 4th edn, pp. 783–823, New York: W. B. Saunders.
Ghebrekidan, H. Ruden, U., Cox, S.et al. (1999). Prevalence of herpes simplex virus types 1 and 2, cytomegalovirus, and varicella-zoster virus infections in Eritrea. J. Clin. Virol., 12, 53–64.Google Scholar
Gilden, D. H. (2005). Varicella-zoster virus vaccine – grown-ups need it too. N. Engl. J. Med., 352(22), 2344–2345.CrossRefGoogle Scholar
Glynn, C., Crockford, G., Gavaghan, D.et al. (1990). Epidemiology of shingles. J. Roy. Soc. Med., 83(10), 617–619.CrossRefGoogle ScholarPubMed
Goh, C. L. and Khoo, L. (1997). A retrospective study of the clinical presentation and outcome of herpes zoster in a tertiary dermatology outpatient referral clinic. Int. J. Dermatol., 36(9), 667–672.CrossRefGoogle Scholar
Guess, H. A., Broughton, D. D., Melton, L. J. II, and Kurland, L. T. (1985). Epidemiology of herpes zoster in children and adolescents: a population-based study. Pediatrics, 76, 512–517.Google ScholarPubMed
Guess, H. A., Broughton, D. D., Melton, L. J. III.et al. (1986). Population-based studies of varicella complications. Pediatrics, 78, S723–S727.Google ScholarPubMed
Guinee, V. F., Guido, J. J., Pfalzgraf, K. A.et al. (1985). The incidence of herpes zoster in patients with Hodgkin's disease. An analysis of prognostic factors. Cancer, 56(3), 642–648.3.0.CO;2-N>CrossRefGoogle ScholarPubMed
Haanpaa, M., Laippala, P., and Nurmikko, T. (2000). Allodynia and pinprick hypesthesia in acute herpes zoster, and the development of postherpetic neuralgia. J. Pain Symptom Manage., 20(1), 50–58.CrossRefGoogle ScholarPubMed
Hardy, I., Gershon, A. A., Steinberg, S. P., and LaRussa, P., (1991). The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. N. Engl. J. Med., 325(22), 1545–1550.CrossRefGoogle ScholarPubMed
Helgason, S., Petursson, G., Gudmundsson, S., and Sigurdsson, J. A. (2000). Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up. Br. Med. J., 321, 794–796.CrossRefGoogle ScholarPubMed
Hope-Simpson, R. E. (1952). Infectiousness of communicable diseases in the household (measles, chickenpox and mumps). Lancet, ii, 549–554.CrossRefGoogle Scholar
Hope-Simpson, R. E. (1965). The nature of herpes zoster: a long-term study and a new hypothesis. Proc. Roy. Soc. Med., 58, 2–20.Google Scholar
Hurwitz, E. S., Gunn, W. J., Pinsky, P. F.et al. (1991). Risk of respiratory illness associated with day-care attendance: a nationwide study. Pediatrics, 87, 62–69.Google ScholarPubMed
Izurieta, H. S., Strebel, P. M., and Blake, P. A. (1997). Postlicensure effectiveness of varicella vaccine during an outbreak in a child care center. J. Am. Med. Assoc., 278, 1495–1499.CrossRefGoogle Scholar
Jeena, P. M., Wesley, A. G., and Coovadia, H. M. (1998). Infectious diseases at the paediatric isolation units of Clairwood and King Edward VII hospitals, Durben. Trends in admission and mortality rates (1985–1996) and the early impact of HIV (1994–1996). S. Afr. Med. J., 88(7), 867–872.Google Scholar
Jerant, A. F., DeGaetano, J. S., Epperly, T. D.et al. (1998). Varicella susceptibility and vaccination strategies in young adults. J. Am. Board Fam. Pract., 11, 296–306.CrossRefGoogle ScholarPubMed
Jezek, Z., Basu, R. N., and Arya, Z. S. (1978a). Investigation of smallpox suspected cases in the final stage of Indian smallpox eradication programme. Ind. J. Public Health, 22(1), 107–112.Google Scholar
Jezek, Z., Basu, R. N., Arya, Z. S.et al. (1978b). Fever with rash surveillance in India. Ind. J. Public Health, 22(1), 120–126.Google Scholar
Johnson, R. W., Consequences and management of pain in herpes zoster. (2002). J. Infect. Dis., 15, 186 (Suppl 1), S83–90. Review.CrossRefGoogle Scholar
Jumaan, A. O., Yu, O., Jackson, L. A., Bohlke, K., Galil, K., and Seward, J. F. (2005). Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992–2002. J. Infect. Dis., 191(12), 2002–2007.CrossRefGoogle ScholarPubMed
Kanra, G., Tezcan, S., Badur, S. and the Turkish National Study Team. (2002). Varicella seroprevalence in a random sample of the Turkish population. Vaccine, 20(9–10), 1425–1428.CrossRefGoogle Scholar
Kilgore, P. E., Kruszon-Moran, D., Seward, J. F.et al. (2003). Varicella in Americans from NHANES III: implications for control through routine immunization. J. Med. Virol., 70(Suppl 1), S111–S118.CrossRefGoogle ScholarPubMed
Kurokawa, I., Kumano, K., Murakawa, K.et al. (2002). Clinical correlates of prolonged pain in Japanese patients with acute herpes zoster. J. Int. Med. Res., 30(1), 56–65.CrossRefGoogle ScholarPubMed
Laforet, E. G. and Lynch, C. L. (1947). Multiple congenital defects following maternal varicella. N. Engl. J. Med., 236(15), 534–537.CrossRefGoogle ScholarPubMed
Lam, M. S., Chew, S. K., Allen, D. M., and Monteiro, E. H. (1993). Fatal varicella infections in Singapore. Singapore Med. J., 34, 213–215.Google ScholarPubMed
Lee, B. W. (1998). Review of varicella zoster seroepidemiology in India and Southeast Asia. Trop. Med. Int. Health, 3(11), 886–890. Review.CrossRefGoogle ScholarPubMed
Levin, M. J. (2001). Use of varicella vaccines to prevent herpes zoster in older individuals. Arch. Virol. Suppl, 17, 151–160. Review.Google Scholar
Levin, M. J., Barber, D., Goldblatt, E.et al. (1998). Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: duration of booster effect. J. Infect. Dis., 178(Suppl 1), S109–S112.CrossRefGoogle ScholarPubMed
Levin, M. J., Smith, J. G., Kaufhold, R. M.et al. (2003). Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-hose VZV vaccine. J. Infect. Dis., 188(9), 1336–1344.CrossRefGoogle ScholarPubMed
Lin, F. and Hadler, J. L. (2000). Epidemiology of primary varicella and herpes zoster hospitalizations: the pre-varicella vaccine era. J. Infect. Dis., 181(6), 1897–1905.CrossRefGoogle ScholarPubMed
Locksley, R. M., Flournoy, N., Sullivan, K. M.et al. (1985). Infection with varicella-zoster virus after marrow transplantation. J. Infect. Dis., 152(6), 1172–1181.CrossRefGoogle ScholarPubMed
Lojeski, E. and Stevens, R. A. (2000). Postherpetic neuralgia in the cancer patient. Curr. Rev. Pain, 4(3), 219–226.CrossRefGoogle ScholarPubMed
Lolekha, S., Tanthiphabha, W., Sornchai, P.et al. (2001). Effect of climatic factors and population density on varicella zoster virus epidemiology within a tropical country. Am. J. Trop. Med. Hyg., 64, 131–136.CrossRefGoogle ScholarPubMed
MacIntyre, C. R., Chu, C. P., and Burgess, M. A. (2003). Use of hospitalization and pharmaceutical prescribing data to compare the prevaccination burden of varicella and herpes zoster in Australia. Epidemiol. Infect., 131(1), 675–682.Google Scholar
Mandal, B. K., Mukherjee, P. P., Murphy, C.et al. (1998). Adult susceptibility to varicella in the tropics is a rural phenomenon due to lack of previous exposure. J. Infect. Dis., 178(Suppl.), S52–S54.CrossRefGoogle ScholarPubMed
McGregor, R. M. (1957). Herpes zoster, chicken pox and cancer in general practice. Br. Med. J., 1, 84–87.Google Scholar
McNulty, A., Li, Y., Radtke, U.et al. (1997). Herpes zoster and the stage and prognosis of HIV-1 infection. Genitourin. Med., 73(6), 467–470.Google Scholar
Meyer, A., Seward, J. F., Jumaan, A. O., and Wharton, M. (2000). Varicella mortality: trends before vaccine licensure in the United States, 1970–94. J. Infect. Dis., 182, 383–390.CrossRefGoogle Scholar
Miller, A. E. (1980). Selective decline in cellular immune response to varicella-zoster in the elderly. Neurology, 30(6), 582–587.CrossRefGoogle ScholarPubMed
Morgan, D., Mahe, C., Malamba, S.et al. (2001). Herpes zoster and HIV-1 infection in a rural Ugandan cohort. AIDS, 15(2), 223–229.CrossRefGoogle Scholar
Nader, S., Bergen, R., Sharp, M., and Arvin, A. M. (1995). Age-related differences in cell-mediated immunity to varicella-zoster virus among children and adults immunized with live attenuated varicella vaccine. J. Infect. Dis., 171(1), 13–17.CrossRefGoogle ScholarPubMed
Nagasako, E. M., Johnson, R. W., Griffin, D. R.et al. (2002). Rash severity in herpes zoster: correlates and relationship to postherpetic neuralgia. J. Am. Acad. Dermatol., 46(6), 834–839.CrossRefGoogle ScholarPubMed
Nguyen, H., Jumaan, A. O., and Seward, J. F. (2005). Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N. Engl. J. Med., 352, 450–458.CrossRefGoogle ScholarPubMed
Oh, H. M., Ho, A. Y., Chew, S. K.et al. (1997). Clinical presentation of herpes zoster in a Singapore hospital. Singapore Med. J., 38(11), 471–474.Google Scholar
Ooi, P. L., Goh, K. T., Doraisingham, S., and Ling, A. E. (1992). Prevalence of varicella-zoster virus infection in Singapore. Southeast Asian J. Trop. Med. Public Health, 23, 22–25.Google ScholarPubMed
Opstelten, W., Mauritz, J. W., de Wit, N. J.et al. (2002). Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database. Fam. Pract., 19(5), 471–475.CrossRefGoogle ScholarPubMed
Oxman, M. N. (1995). Immunization to reduce the frequency and severity of herpes zoster and its complications. Neurology, 45 (Suppl. 8), S41–S46.CrossRefGoogle ScholarPubMed
Oxman, M. N., Levin, M. J., Johnson, G. R.et al. (2005). A vaccine to prevent herpes zoster and postherpetic neuragia in order adults. N. Engl. J. Med., 352(22), 2271–2284.CrossRefGoogle Scholar
Palmer, S. R., Caul, E. O., Donald, D. E., Kwantes, W., and Tillett, H. (1985). An outbreak of shingles?Lancet, 2(8464), 1108–1111.CrossRefGoogle ScholarPubMed
Petursson, G., Helgason, S., Gudmundsson, S.et al. (1998). Herpes zoster in children and adolescents. Pediatr. Infect. Dis. J., 17(10), 905–908.CrossRefGoogle ScholarPubMed
Ragozzino, M. W., Melton, L. J. 3rd, Kurland, L. T.et al. (1982). Population-based study of herpes zoster and its sequelae. Medicine (Baltimore), 61(5), 310–316.CrossRefGoogle ScholarPubMed
Ratner, A. J. (2002). Varicella-related hospitalizations in the vaccine era. Pediatr. Infect. Dis. J., 21, 927–930.CrossRefGoogle ScholarPubMed
Rawson, H., Crampin, A., and Noah, N. (2001). Deaths from chickenpox in England and Wales 1995–97: analysis of routine mortality date. Br. Med. J., 323, 1091–1093.CrossRefGoogle Scholar
Reigle, L. and Cooperstock, M. (1985). Contagiousness of zoster in a day care setting. Pediatr. Infect. Dis., 4(4), 413.CrossRefGoogle Scholar
Reis, A. D., Pannuti, C. S., and de Souza, V. A. (2003). Prevalence of varicella-zoster virus antibodies in young adults from different Brazilian climatic regions. Rev. Soc. Bras. Med. Trop., 36(3), 317–320. Epub 2003 Jul 31.CrossRefGoogle ScholarPubMed
Ross, A. H. (1962). Modification of chickenpox in family contacts by administration of gamma globulin. N. Engl. J. Med., 267, 369–376.CrossRefGoogle ScholarPubMed
Ross, A. M. and Fleming, D. M. (2000). Chickenpox increasingly affects preschool children. Commun. Dis. Public Health, 3, 213–215.Google ScholarPubMed
Rusthoven, J. J. (1994). The risk of varicella-zoster infections in different patient populations: a critical. Transfus. Med. Rev., 8(2), 96–116.CrossRefGoogle ScholarPubMed
Rusthoven, J. J., Ahlgren, P., Elhakim, T.et al. (1988). Risk factors for varicella zoster disseminated infection among adult cancer patients with localized zoster. Cancer, 62(8), 1641–1646.3.0.CO;2-D>CrossRefGoogle ScholarPubMed
Rusthoven, J. J., Ahlgren, P., Elhakim, T.et al. (1988). Varicella-zoster infection in adult cancer patients. A population study. Arch. Intern. Med., 148(7), 1561–1566.CrossRefGoogle ScholarPubMed
Ryan, M. A., Smith, T. C., Honner, W. K.et al. (2003). Varicella susceptibility and vaccine use among young adults enlisting in the United States Navy. J. Med. Virol., 70(Suppl 1), S15–S19.CrossRefGoogle ScholarPubMed
Schimpff, S., Serpick, A., Stoler, B.et al. (1972). Varicella-Zoster infection in patients with cancer. Ann. Intern. Med., 76(2), 241–254.CrossRefGoogle ScholarPubMed
Schmader, K. (2000). Epidemiology of herpes zoster. In Arvin, A. and Gershon, A., eds. Varicella-Zoster Virus, pp. 220–245, Cambridge: Cambridge University Press.CrossRefGoogle ScholarPubMed
Schmader, K. (2001). Herpes zoster in older adults. Clin. Infect. Dis., 32(10), 1481–1486.Google ScholarPubMed
Schmader, K., Studenski, S., MacMillan, J.et al. (1990). Are stressful life events risk factors for herpes zoster?J. Am. Geriatr. Soc., 38(11), 1188–1194.CrossRefGoogle ScholarPubMed
Schmader, K., George, L. K., Burchett, B. M.et al. (1995). Racial differences in the occurrence of herpes zoster. J. Infect. Dis., 171(3), 701–704.CrossRefGoogle ScholarPubMed
Schmader, K., George. L. K., Burchett, B. M.et al. (1998). Race and stress in the incidence of herpes zoster in older adults. J. Am. Geriatr. Soc., 46(8), 973–977.CrossRefGoogle ScholarPubMed
Schoub, B. D., Johnson. S., McAnerney, J. M.et al. (1985). Prevalence of antibodies to varicella zoster virus in healthy adults. S. Afr. Med. J., 8, 67(23), 929–931.Google ScholarPubMed
Schuchter, L. M., Wingard, J. R., Piantadosi, S.et al. (1989). Herpes zoster infection after autologous bone marrow transplantation. Blood, 74(4), 1424–1427.Google ScholarPubMed
Seiler, H. E. (1949). A study of herpes zoster particularly in relation to chickenpox. J. Hyg. (Lond.), 47, 253–262.CrossRefGoogle Scholar
Seward, J. Meyer, P., Singleton, J. et al. (1998). Varicella incidence and mortality, USA 1970–1994. Infectious Disease Society of America. 36th Annual Meeting, Denver, CO.
Seward, J., Galil, K., and Wharton, M. (2000). Epidemiology of varicella. In Arvin, A. and Gershon, A., eds. Varicella-Zoster Virus, pp. 187–205. Cambridge University Press.CrossRefGoogle ScholarPubMed
Seward, J. F., Watson, B. M., Peterson, C. L.et al. (2002). Varicella disease after introduction of varicella vaccine in the United States, 1995–2000. J. Am. Med. Assoc., 287, 606–611.CrossRefGoogle ScholarPubMed
Socan, M., Kraigher, A., and Pahor, L. (2001). Epidemiology of varicella in Slovenia over a 20-year period (1979–1998). Epidemiol. Infect., 126, 279–283.CrossRefGoogle Scholar
Solomon, B. A., Kaporis, A. G., Glass, A. T. et al. (1998). Lasting immunity to varicella in doctors study (L. I. V. I. D. study). Am. Acad. Dermatol., 38, 763–765.CrossRef
Stankus, S. J., Dlugopolski, M., Packer, D.et al. (2000). Management of herpes zoster (shingles) and postherpetic neuralgia. Am. Fam. Physician, 61(8), 2437–2444, 2447–2448. Review.Google ScholarPubMed
Takayama, N., Yamada, H., Kaku, H.et al. (2000). Herpes zoster in immunocompetent and immunocompromised Japanese. Pediatr. Int., 42(3), 275–279.CrossRefGoogle ScholarPubMed
Terada, K., Hirago, U., Kawano, S.et al. (1995). Incidence of herpes zoster in pediatricians and history of reexposure to varicella-zoster virus in patients with herpes zoster. Kansenshogaku Zasshi, 69(8), 908–912.CrossRefGoogle ScholarPubMed
Thiry, N., Beutels, P., Shkedy, Z.et al. (2002). The seroepidemiology of primary varicella-zoster virus infection in Flanders (Belgium). Eur. J. Pediatr., 161, 588–593.CrossRefGoogle Scholar
Thomas, S. L., and Hall, A. J., (2004). What does epidemiology tell us about risk factors for herpes zoster?. Lancet Infect. Dis., 4(1), 26–33 Review.CrossRefGoogle ScholarPubMed
Thomas, S. L., Wheeler, J. G., Hall, A. J.et al. (2002). Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study. Lancet, 31, 360 (9334), 678–682.CrossRefGoogle Scholar
Tobias, M., Reid, S., Lennon, D.et al. (1998). Chickenpox immunization in New Zealand. N Z Med. J., 111, 274–281.Google ScholarPubMed
Tzeng, C. H., Liu, J. H., Fan, S.et al. (1995). Varicella zoster virus infection after allogeneic or autologous hemopoietic stem cell transplantation. Factors contributing to severity of herpes zoster in children. Pediatrics, 67(5), 763–771.Google Scholar
Veenstra, J., Praag, R. M., Krol, A.et al. (1996) Complications of varicella zoster virus reactivation in HIV-infected homosexual men. AIDS, 10(4), 393–399.CrossRefGoogle ScholarPubMed
Vynnycky, E.Gay, N. J., and Cutts, F. T. (2003). The predicted impact of private sector MMR vaccination on the burden of Congenital Rubella Syndrome. Vaccine, 21(21–22), 2708–2719.CrossRefGoogle ScholarPubMed
Wharton, M. (1996). The epidemiology of varicella-zoster virus infections. Infect. Dis. Clin. North. Am., 10(3), 571–581.CrossRefGoogle ScholarPubMed
Whitley, R. J., Shukla, S., Crooks, R. J.et al. (1998). The identification of risk factors associated with persistent pain following herpes zoster. J. Infect. Dis., 178(Suppl 1), S710–S715.CrossRefGoogle ScholarPubMed
Whitley, R. J., Weiss, H. L., Soong, S. J.et al. (1999). Herpes zoster: risk categories for persistent pain. J. Infect. Dis., 179, 9–15.CrossRefGoogle ScholarPubMed
Wilson, J. B. (1986) Thirty one years of herpes zoster in a rural practice. Br. Med. J. (Clin. Res. edn), 293, 1349–1351.CrossRefGoogle Scholar
Yawn, B. P., Yawn, R. A., and Lydick, E. (1997). Community impact of childhood varicella infections. J. Pediatr., 130, 759–765.CrossRefGoogle ScholarPubMed
Yih, W. K., Brooks, D. R., Lett, S. M.et al. (2005). The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998–2003. BMC Public Health, 5(1), 68.CrossRefGoogle ScholarPubMed
Yorke, J. A. and London, W. P. (1973). Recurrent outbreaks of measles, chickenpox and mumps. II. Systematic differences in contact rates and stochastic effects. Am. J. Epidemiol., 98(6), 469–482.CrossRefGoogle ScholarPubMed
Zak-Prelich, M., Borkowski, J. L., Alexander, F.et al. (2000). The role of solar ultraviolet irradiation in zoster. Epidemiol. Infect, 129(3), 593–597.CrossRefGoogle Scholar
Zhou, F., Harpaz, R., Jumaan, A. O., Winston, C. A., and Shefer, A. (2005). Impact of varicella vaccination on health care utilization. J. Am. Med. Assoc., 294(7), 797–802.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×